Cubist Systematic Strategies, LLC Maravai Lifesciences Holdings, Inc. Transaction History

Cubist Systematic Strategies, LLC

$15.8 Billion
Q3 2024

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$6.87 - $11.34 $521,824 - $861,352	-75,957 Reduced 21.09%	284,146 $2.03 Million
Q1 2024 May 15, 2024	BUY	$5.11 - $8.76 $1.27 Million - $2.17 Million	247,707 Added 220.39%	360,103 $3.12 Million
Q4 2023 Feb 14, 2024	BUY	$4.7 - $9.87 $528,261 - $1.11 Million	112,396 New	112,396 $736,000
Q2 2023 Aug 14, 2023	SELL	$12.09 - $15.0 $1.98 Million - $2.45 Million	-163,371 Reduced 96.11%	6,618 $82,000
Q1 2023 May 15, 2023	SELL	$12.99 - $16.48 $1.65 Million - $2.09 Million	-126,750 Reduced 42.71%	169,989 $2.38 Million
Q4 2022 Feb 14, 2023	BUY	$12.5 - $24.78 $3.68 Million - $7.29 Million	294,199 Added 11582.64%	296,739 $4.25 Million
Q3 2022 Nov 14, 2022	SELL	$20.6 - $30.37 $4.17 Million - $6.15 Million	-202,385 Reduced 98.76%	2,540 $65,000
Q2 2022 Aug 15, 2022	BUY	$26.05 - $37.48 $551,921 - $794,088	21,187 Added 11.53%	204,925 $5.82 Million
Q1 2022 May 16, 2022	BUY	$24.46 - $40.92 $2.42 Million - $4.05 Million	99,047 Added 116.95%	183,738 $6.48 Million
Q4 2021 Feb 14, 2022	SELL	$35.0 - $45.94 $1.27 Million - $1.67 Million	-36,267 Reduced 29.98%	84,691 $3.55 Million
Q3 2021 Nov 15, 2021	BUY	$36.8 - $60.62 $944,361 - $1.56 Million	25,662 Added 26.93%	120,958 $5.94 Million
Q2 2021 Aug 16, 2021	BUY	$32.46 - $45.0 $1.04 Million - $1.44 Million	31,902 Added 50.32%	95,296 $3.98 Million
Q1 2021 May 17, 2021	SELL	$25.8 - $38.49 $371,391 - $554,063	-14,395 Reduced 18.51%	63,394 $2.26 Million
Q4 2020 Feb 16, 2021	BUY	$24.5 - $30.86 $1.91 Million - $2.4 Million	77,789 New	77,789 $2.18 Million

Others Institutions Holding MRVI

# of Institutions

235

Shares Held

141M

Call Options Held

223K

Put Options Held

19.4K

View Full List

About MARAVAI LIFESCIENCES HOLDINGS, INC.

Ticker MRVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 131,540,000
Market Cap $687M
Description
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...

More about MRVI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account